New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research using Zebrafish
- Prykhozhij, S.V., Caceres, L., Berman, J.N.
- Current gene therapy 17(4): 286-300 (Review)
- Registered Authors
- Berman, Jason, Caceres, Lucia, Prykhozhij, Sergey
- CRISPR, Cas9, Genetic Screen, Sgrna, Single-Cell RNA Sequencing, Zebrafish
- MeSH Terms
- CRISPR-Cas Systems*
- Gene Editing/methods*
- Zebrafish Proteins/genetics
- 29173171 Full text @ Curr Gene Ther
Prykhozhij, S.V., Caceres, L., Berman, J.N. (2017) New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research using Zebrafish. Current gene therapy. 17(4):286-300.
Genome editing using CRISPR/Cas9 has advanced very rapidly in its scope, versatility and ease of use. Zebrafish (Danio rerio) has been one of the vertebrate model species where CRISPR/Cas9 has been applied very extensively for many different purposes and with great success. In particular, disease modeling in zebrafish is useful for testing specific gene variants for pathogenicity in a preclinical setting. Here we describe multiple advances in diverse species and systems that can improve genome editing in zebrafish. To achieve temporal and spatial precision of genome editing, many new technologies can be applied in zebrafish such as artificial transcription factors, drug-inducible or optogenetically-driven expression of Cas9, or chemically-inducible activation of Cas9. Moreover, chemically- or optogenetically-inducible reconstitution of dead Cas9 (catalytically inactive, dCas9) can enable spatiotemporal control of gene regulation. In addition to controlling where and when genome editing occurs, using oligonucleotides allows for the introduction (knock-in) of precise modifications of the genome. We review recent trends to improve the precision and efficiency of oligo-based point mutation knock-ins and discuss how these improvements can apply to work in zebrafish. Similarly to how chemical mutagenesis enabled the first genetic screens in zebrafish, multiplexed sgRNA libraries and Cas9 can enable the next revolutionary transition in how genetic screens are performed in this species. We discuss the first examples and prospects of approaches using sgRNAs as specific and effective mutagens. Moreover, we have reviewed methods aimed at measuring the phenotypes of single cells after their mutagenic perturbation with vectors encoding individual sgRNAs. These methods can range from different cell-based reporters to single-cell RNA sequencing and can serve as great tools for high-throughput genetic screens.
Genes / Markers
Mutation and Transgenics
Human Disease / Model Data
Sequence Targeting Reagents
Engineered Foreign Genes
Errata and Notes